Advertisement

< Back to Article

Seroepidemiology of Human Polyomaviruses

Figure 2

Seroreactivity to VP1 proteins after competition with soluble heterologous VP1 pentamers.

A) SV40 seroreactivity competed with BKV; B) BKV seroreactivity competed with SV40; C) KIV seroreactivity competed with WUV; D) WUV seroreactivity competed with KIV; E) MCV isolate 350 seroreactivity competed with MCV isolate 339 and LPV; F) MCV isolate 339 seroreactivity competed with MCV isolate 350 and LPV; and G) LPV seroreactivity competed with MCV isolates 350 and 339. All capsid proteins were competed with themselves as well as with soluble GST as controls.

Figure 2

doi: https://doi.org/10.1371/journal.ppat.1000363.g002